Insider selling
Traded Aug 27, 2025 · filed 1 day laterNot reported under a pre-arranged trading plan
An Amneal Pharmaceuticals director sold $295K of Amneal Pharmaceuticals shares. The filing does not indicate a pre-arranged trading plan.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
AMRX · NASDAQ · Pharmaceuticals
Amneal Pharmaceuticals (AMRX) · oqro.io/stocks/AMRX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$21.12−0.27 (−1.26%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Insider selling
Traded Aug 27, 2025 · filed 1 day laterNot reported under a pre-arranged trading plan
An Amneal Pharmaceuticals director sold $295K of Amneal Pharmaceuticals shares. The filing does not indicate a pre-arranged trading plan.
Traded Aug 22 – Aug 25, 2025 · largest single transaction ~$1.11MNot reported under a pre-arranged trading plan
Aug 22, 2025~$1.11M · 114K sh @ $9.66
DetailsInsider selling
Traded Aug 20, 2025 · filed 2 days laterNot reported under a pre-arranged trading plan
Amneal Pharmaceuticals's Executive Vice President sold $2.62M of Amneal Pharmaceuticals shares. The filing does not indicate a pre-arranged trading plan.
Traded Aug 13 – Aug 15, 2025 · largest single transaction ~$2.07MNot reported under a pre-arranged trading plan
Aug 15, 2025~$2.07M · 219K sh @ $9.43
DetailsTraded Aug 12 – Aug 14, 2025 · largest single transaction ~$666KNot reported under a pre-arranged trading plan
Aug 14, 2025~$666K · 72K sh @ $9.29
DetailsInsider selling
Traded Aug 12, 2025 · filed 1 day laterNot reported under a pre-arranged trading plan
Amneal Pharmaceuticals's Executive Vice President sold $303K of Amneal Pharmaceuticals shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Aug 12, 2025 · filed 1 day laterNot reported under a pre-arranged trading plan
Amneal Pharmaceuticals's Chief Legal Officer sold $199K of Amneal Pharmaceuticals shares. The filing does not indicate a pre-arranged trading plan.
Gautam Patel (Director) sold ~$761K of Amneal Pharmaceuticals
Planned saleInsider selling
Traded Jun 10, 2025 · filed 2 days laterNot reported under a pre-arranged trading plan
An Amneal Pharmaceuticals director sold $453K of Amneal Pharmaceuticals shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded May 16, 2025 · filed 3 days laterNot reported under a pre-arranged trading plan
Amneal Pharmaceuticals's Executive Vice President sold $372K of Amneal Pharmaceuticals shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded May 12, 2025 · filed 1 day laterNot reported under a pre-arranged trading plan
An Amneal Pharmaceuticals director sold $380K of Amneal Pharmaceuticals shares. The filing does not indicate a pre-arranged trading plan.
Gautam Patel (Director) sold ~$39K of Amneal Pharmaceuticals
Planned saleGautam Patel (Director) sold ~$30K of Amneal Pharmaceuticals
Planned saleGautam Patel (Director) sold ~$664K of Amneal Pharmaceuticals
Planned saleInsider selling
Traded Mar 14, 2025 · filed 3 days laterNot reported under a pre-arranged trading plan
A major shareholder of Amneal Pharmaceuticals sold $41.8M of Amneal Pharmaceuticals shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Mar 5, 2025 · filed 2 days laterNot reported under a pre-arranged trading plan
The CFO of Amneal Pharmaceuticals sold $891K of Amneal Pharmaceuticals shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Mar 5, 2025 · filed 2 days laterNot reported under a pre-arranged trading plan
Amneal Pharmaceuticals's Executive Vice President sold $1.11M of Amneal Pharmaceuticals shares. The filing does not indicate a pre-arranged trading plan.
Insider selling
Traded Mar 5, 2025 · filed 2 days laterNot reported under a pre-arranged trading plan
An Amneal Pharmaceuticals director sold $712K of Amneal Pharmaceuticals shares. The filing does not indicate a pre-arranged trading plan.
Traded Mar 5 – Mar 6, 2025 · largest single transaction ~$410KNot reported under a pre-arranged trading plan
Mar 6, 2025~$410K · 47K sh @ $8.73
DetailsGautam Patel (Director) sold ~$712K of Amneal Pharmaceuticals
Planned saleGautam Patel (Director) sold ~$651K of Amneal Pharmaceuticals
Planned saleGautam Patel (Director) sold ~$501K of Amneal Pharmaceuticals
Planned saleGautam Patel (Director) sold ~$139K of Amneal Pharmaceuticals
Planned saleInsider selling
Traded Nov 22, 2024 · filed 4 days laterNot reported under a pre-arranged trading plan
An Amneal Pharmaceuticals director sold $143K of Amneal Pharmaceuticals shares. The filing does not indicate a pre-arranged trading plan.
Traded Nov 21 – Nov 22, 2024 · largest single transaction ~$277KNot reported under a pre-arranged trading plan
Nov 22, 2024~$277K · 33K sh @ $8.34
DetailsTraded Nov 15 – Nov 21, 2024 · largest single transaction ~$376KNot reported under a pre-arranged trading plan
Nov 21, 2024~$115K · 14K sh @ $8.40
DetailsAug 25, 2025~$60K · 6,340 sh @ $9.50
DetailsOfficial recordAug 13, 2025~$1.49M · 161K sh @ $9.22
DetailsOfficial recordAug 14, 2025~$1.11M · 119K sh @ $9.30
DetailsOfficial recordAug 12, 2025~$452K · 50K sh @ $9.04
DetailsOfficial recordMar 5, 2025~$382K · 43K sh @ $8.88
DetailsOfficial recordNov 21, 2024~$57K · 6,771 sh @ $8.41
DetailsOfficial recordNov 15, 2024~$376K · 44K sh @ $8.61
DetailsOfficial record0 open-market purchases and 5 open-market sales by insiders of AMRX between Mar 23, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 3, 2026. The data provider lists the next release for Feb 25, 2027; that date may change.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Nov 3, 2026 | None | None | None |
| Jul 30, 2026 | None | None | 4 sales |
| May 7, 2026 | None | None | 1 sale |
| Apr 22, 2026 | None | None | 1 sale |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies